Medications for Hepatitis
6 results
Epclusa access (velpatasvir and sofosbuvir)
(Velpatasvir and Sofosbuvir)Gilead Sciences Inc
Usage: EPCLUSA™ is indicated for treating chronic hepatitis C virus (HCV) infections in adults and pediatric patients aged 6 years and older, with specific genotypes (1-6). It is effective for those without cirrhosis or with compensated cirrhosis, and in combination with ribavirin for decompensated cirrhosis cases.
Hyperhep b (hepatitis b immune globulin (human))
(HEPATITIS B IMMUNE GLOBULIN (HUMAN))GRIFOLS USA, LLC
Usage: HyperHEP B is indicated for post-exposure prophylaxis against hepatitis B virus in cases of acute exposure to HBsAg-positive blood, perinatal exposure in infants from HBsAg-positive mothers, sexual exposure to HBsAg-positive individuals, and household exposure to persons with acute HBV infection.
Mavyret (glecaprevir and pibrentasvir)
(Glecaprevir and Pibrentasvir)AbbVie Inc.
Usage: MAVYRET is indicated for treating chronic hepatitis C virus (HCV) genotypes 1-6 in patients aged 3 and older, including those with or without cirrhosis. It is also for patients with HCV genotype 1 who have previously received treatment with an NS5A inhibitor or an NS3/4A protease inhibitor.
Sofosbuvir and velpatasvir (velpatasvir and sofosbuvir)
(Velpatasvir and Sofosbuvir)Asegua Therapeutics LLC
Usage: Sofosbuvir and velpatasvir is indicated for treating chronic hepatitis C virus (HCV) genotype 1-6 infection in adults and pediatric patients aged 3 years and older, including those without cirrhosis, with compensated cirrhosis, or with decompensated cirrhosis in combination with ribavirin.
Sovaldi access (sofosbuvir)
(SOFOSBUVIR)Gilead Sciences Inc
Usage: SOVALDI is indicated for treating chronic hepatitis C virus (HCV) in adults and pediatric patients aged 12 and older. It is used in combination with other antiviral agents for specific HCV genotypes, addressing those with or without cirrhosis.
Vosevi (sofosbuvir, velpatasvir, and voxilaprevir)
(SOFOSBUVIR, VELPATASVIR, and VOXILAPREVIR)Gilead Sciences Inc
Usage: VOSEVI is indicated for adult patients with chronic hepatitis C virus (HCV) infection without cirrhosis or with compensated cirrhosis (Child-Pugh A) who have specific genotypes and have previously been treated with certain HCV regimens.